The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR/ARHP Annual Meeting 2012: Understanding Pain Signals May Pave Path to More Effective Therapies

ACR/ARHP Annual Meeting 2012: Understanding Pain Signals May Pave Path to More Effective Therapies

February 1, 2013 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

WASHINGTON, D.C.—A deeper understanding of the mechanisms of pain and why some people become hypersensitive to typically innocuous stimuli may one day lead to more effective, targeted pain therapies, said Clifford Woolf, MD, PhD, a neurobiologist at Children’s Hospital of Boston and professor of neurology at Harvard Medical School in Boston, in a lecture titled, “Mechanisms of Pain in Rheumatic Diseases,” at the 2012 ACR/ARHP Annual Meeting, held here November 9–14. [Editor’s Note: This session was recorded and is available via ACR SessionSelect at www.rheumatology.org.]

You Might Also Like
  • 2015 ACR/ARHP Annual Meeting: How Gender Differences Affect Pain
  • ACR/ARHP Annual Meeting 2012: New Insights into Bone Erosion and Formation Heighten Prospects for Therapies
  • ACR/ARHP Annual Meeting 2012: Children Experience Pain Differently from Adults
Explore This Issue
February 2013
Also By This Author
  • Global Perspectives on Managing Rheumatoid Arthritis Addressed at the 2013 ACR/ARHP Annual Meeting

There are different types of pain, and differentiating these types is an important tool in the diagnosis and treatment of disease, said Dr. Woolf. Nociceptive pain, the sensing of noxious stimuli, requires intense stimuli for activation, such as extreme heat, cold, or chemical irritants. Our skin is densely packed with nociceptive fibers that help us detect noxious stimuli. In patients with inflammatory pain, neuropathic pain related to neuronal damage, or dysfunctional pain that occurs despite the absence of inflammation or nervous system damage, there typically is a low pain threshold.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Nociceptive pain serves an important physiological purpose, Dr. Woolf said. “The pain itself has a very unpleasant quality, but this has a key protective factor,” he added. “We not only withdraw from the stimuli, but we learn from it. This is most forcefully taught to us when we see patients with congenital insensitivity to pain. Indeed, their life expectancy is reduced.”

Key proteins are involved in the transduction of pain signals in the nervous system. The first of these proteins to be isolated and cloned was TRPV1, which is activated by capsaicin and helps us recognize noxious heat. Identifying these led to the development of potential pain therapies like TRPV1 antagonists and protein kinase C inhibitors, which are now in clinical trials.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pain Hypersensitivity

Some patients develop a pain hypersensitivity, Dr. Woolf said. These patients’ pain threshold is lower than normal, and the duration of their pain response may be long lasting. There are two main mechanisms of pain hypersensitivity: peripheral sensitization and central sensitization. Peripheral sensitization is associated with inflammation and tissue damage found in many rheumatic diseases. It’s marked by a lower pain threshold and an increase in the patient’s response to the peripheral ends of nociceptors, the nerve cell endings that send pain signals to the brain in response to stimuli.

Peripheral sensitization is the result of changes in transduction proteins that affect the excitability of nociceptors. Noxious stimuli, like excessive heat, are converted to an electric response in the nervous system via these proteins. Normally, humans begin to find heat painful at approximately 108° Fahrenheit, but after peripheral sensitization, that threshold may fall. Proteins like TRPV1 may be involved in this process. A warm shower may feel painfully hot, for example, Dr. Woolf said.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports Tagged With: Pain, Rheumatic Disease, therapy, TreatmentIssue: February 2013

You Might Also Like:
  • 2015 ACR/ARHP Annual Meeting: How Gender Differences Affect Pain
  • ACR/ARHP Annual Meeting 2012: New Insights into Bone Erosion and Formation Heighten Prospects for Therapies
  • ACR/ARHP Annual Meeting 2012: Children Experience Pain Differently from Adults
  • ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.